Zydus Lifesciences (BOM:532321) YoY EPS Growth : 297.62% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Zydus Lifesciences YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Zydus Lifesciences's YoY EPS Growth for the quarter that ended in Mar. 2024 was 297.62%.

Zydus Lifesciences's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ₹11.69.

Zydus Lifesciences YoY EPS Growth Historical Data

The historical data trend for Zydus Lifesciences's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zydus Lifesciences YoY EPS Growth Chart

Zydus Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EPS Growth

Get a 7-Day Free Trial

-36.38

81.38

110.32

-55.97

97.62

Zydus Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EPS Growth	Get a 7-Day Free Trial															-24.23	112.25	53.59	26.83	297.62

Zydus Lifesciences YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Zydus Lifesciences's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (A: Mar. 2024 )
=	(Earnings per Share (Diluted) (A: Mar. 2024 )	-	Earnings per Share (Diluted) (A: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (A: Mar. 2023 ) \|
=	(38.14	-	19.3)	/	\| 19.3 \|
=	97.62 %

Zydus Lifesciences's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EPS Growth (Q: Mar. 2024 )
=	(Earnings per Share (Diluted) (Q: Mar. 2024 )	-	Earnings per Share (Diluted) (Q: Mar. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2023 )) \|
=	(11.69	-	2.94)	/	\| 2.94 \|
=	297.62 %

Zydus Lifesciences YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Zydus Lifesciences's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Zydus Lifesciences (BOM:532321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zydus Lifesciences Ltd (BOM:532321) » Definitions » YoY EPS Growth

Traded in Other Exchanges

ZYDUSLIFE:India

Address

Scheme No. 63, Sarkhej-Gandhinagar Highway, Zydus Corporate Park, Survey No. 536, Near Vaishnodevi Circle, Khoraj (Gandhinagar), Ahmedabad, GJ, IND, 382481

Website

https://www.zyduslife.com

Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.

Zydus Lifesciences (BOM:532321) Headlines

No Headlines